215 Health LLC

DBA Hillside Wellness Center

72 Hillside Lane, Levittown, PA 19054

215 Health LLC DBA Hillside Wellness Center is a residential facility in Levittown, PA offering substance use treatment. Buprenorphine and Naltrexone are used for opioid use disorder. It reports accepting self-payment and private insurance.

Licenses and accreditations

State mental health departmentLicensed by the state's mental health department.
State substance use treatment agencyLicensed by the state's substance use treatment agency.
The Joint CommissionAccredited by The Joint Commission.

Kinds of care

Substance use treatment: Treatment for alcohol and drug use.
Treatment for co-occurring disorders plus serious mental illness (SMI) in adults: Treats substance use together with a serious mental illness in adults.

Settings

Long-term residential: Living at the facility for more than 30 days.
Residential/24-hour residential: Living at the facility during treatment.
Short-term residential: Living at the facility for 30 days or less.

Medications for opioid use

Buprenorphine used in Treatment: Buprenorphine is used here.
Naltrexone used in Treatment: Naltrexone is used here.

Accepts clients using MAT but prescribed elsewhere: Accepts clients whose medication for opioid use is prescribed elsewhere.
Lofexidine or Clonidine detoxification: Lofexidine or clonidine to ease withdrawal during detox.
Prescribes naltrexone: Prescribes naltrexone.
Relapse prevention with naltrexone: Naltrexone to help prevent relapse.

Payment

Accepted: Cash or self-payment; Private health insurance.

Who they serve

Ages served: Adults, 26 to 64; Seniors, 65 and older; Young adults, 18 to 25.
Sex: Female; Male.
Programs for: Adult men; Adult women; Clients who have experienced intimate partner violence, domestic violence; Clients who have experienced sexual abuse; Clients who have experienced trauma; Clients with co-occurring mental and substance use disorders; Pregnant/postpartum women; Seniors or older adults; Young adults.

More details this facility reports

External Opioid Medications Source: No formal relationship with prescribing entity.
Type of Alcohol Use Disorder Treatment: Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder.
External Source of Medications Used for Alcohol Use Disorder Treatment: In-network prescribing entity; No formal relationship with prescribing entity.
Pharmacotherapies: Acamprosate (Campral®); Buprenorphine (extended-release, injectable); Buprenorphine with naloxone; Buprenorphine without naloxone; Clonidine; Disulfiram; Medication for mental disorders; Medications for HIV treatment; Medications for Hepatitis C treatment; Medications for pre-exposure to prophylaxis; Naltrexone (extended-release, injectable); Naltrexone (oral); Nicotine replacement; Non-nicotine smoking/tobacco cessation.
Treatment Approaches: 12-step facilitation; Anger management; Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Trauma-related counseling.
Facility Operation (e.g., Private, Public): Private for-profit organization.
Testing: Breathalyzer or blood alcohol testing; Drug or alcohol urine screening; Metabolic syndrome monitoring.
Transitional Services: Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge.
Other Services: Treatment for other addiction disorder.
Education and Counseling Services: Family counseling; Group counseling; Individual counseling; Substance use disorder education.
Facility Smoking Policy: Smoking permitted in designated area.
Facility Vaping Policy: Vaping permitted in designated area.
Ancillary Services: Mental health services.

Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.